First Business Financial Services, Inc. Emergent Bio Solutions Inc. Transaction History

First Business Financial Services, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$33.11 - $55.01 $416,854 - $692,575	-12,590 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$50.07 - $66.05 $13,018 - $17,173	-260 Reduced 2.02%	12,590 $630,000
Q2 2021 Jul 20, 2021	BUY	$56.61 - $80.46 $158,111 - $224,724	2,793 Added 27.77%	12,850 $809,000
Q1 2021 Apr 20, 2021	BUY	$86.23 - $125.19 $132,707 - $192,667	1,539 Added 18.07%	10,057 $934,000
Q4 2020 Jan 28, 2021	BUY	$79.17 - $111.47 $674,370 - $949,501	8,518 New	8,518 $763,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $404M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of First Business Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on First Business Financial Services, Inc. with notifications on news.